Dubai, UAE, 13 March 2025 – MicroPort® and its associated companies showcased a comprehensive portfolio of advanced medical solutions at the 50th Arab Health Exhibition in Dubai. The event highlighted groundbreaking innovations across multiple fields, including cardiovascular intervention, aortic and peripheral vascular intervention, neurovascular intervention, electrophysiology, surgical robotics, orthopedics, and endocrinology.
MicroPort® presented its latest technologies, drawing significant interest from industry professionals. Key featured products included:
One of the key highlights was MicroPort® MedBot, which showcased its flagship surgical solutions, including the Toumai® robotic laparoscopic surgical system, SkyWalker® orthopedic surgical robot, and DFVision® 3D electronic laparoscope. The Toumai® system captivated audiences with a live demonstration of its remote surgical capabilities. During the session, a surgeon performed a series of complex maneuvers—including precise dissection, traction, and suturing—showcasing the robotic arms' exceptional dexterity, stability, and real-time responsiveness. The demonstration received high praise from attending specialists.
Additionally, the SkyWalker® robotic system, paired with MicroPort® Orthopedics’ Evolution® Medial-Pivot Knee System, also gained widespread recognition. A specialist remarked, "The synergy between SkyWalker® and Evolution® not only represents a breakthrough in surgical technology but also exemplifies a patient-first approach."
Jonathan Chen, Chief International Business Officer at MicroPort®, commented: "Our presence at Arab Health 2025 reinforces our commitment to global healthcare innovation. Throughout the exhibition, we engaged in in-depth discussions with key partners from Gulf countries including Saudi Arabia, UAE and Kuwait. MicroPort® representatives engaged with over 200 potential customers and partners to explore future collaborations. Moving forward, we will continue to advance our long-term global strategy, leveraging our ‘One MicroPort®’ platform to drive innovation and deliver accessible, high-quality medical solutions worldwide."
About MicroPort®
Founded in 1998 on the belief that every person has the right to high quality medical treatments, MicroPort® (MicroPort Scientific Corporation; HKEX: 00853) is a global medical devices company. MicroPort® provides solutions across twelve therapeutic areas, including cardiovascular, orthopedics, cardiac rhythm management, electrophysiology, endovascular, neurovascular and surgical robotics among others. For over 26 years, MicroPort® has been breaking barriers and accelerating access to life-changing solutions so that patients everywhere can continue living better and longer lives. With therapeutic solutions that are available in more than 100 countries and over 20,000 hospitals around the world, today, every 5 seconds a patient around the world benefits from a MicroPort® life-changing solution.
More information is available at www.microport.com